| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestinal Mucosa | 40 | 2015 | 3037 | 2.380 |
Why?
|
| Crohn Disease | 27 | 2021 | 2304 | 1.290 |
Why?
|
| Intestines | 14 | 2010 | 1924 | 1.010 |
Why?
|
| Butyrates | 8 | 2007 | 163 | 0.930 |
Why?
|
| Inflammatory Bowel Diseases | 14 | 2022 | 2428 | 0.860 |
Why?
|
| Growth Disorders | 6 | 2014 | 645 | 0.810 |
Why?
|
| Puberty, Delayed | 2 | 2014 | 115 | 0.660 |
Why?
|
| Insulin-Like Growth Factor I | 9 | 2014 | 2016 | 0.640 |
Why?
|
| Intestine, Small | 14 | 2007 | 1240 | 0.610 |
Why?
|
| Ferrous Compounds | 1 | 2017 | 42 | 0.600 |
Why?
|
| Interleukin-8 | 6 | 2011 | 690 | 0.600 |
Why?
|
| Anemia, Iron-Deficiency | 3 | 2017 | 365 | 0.600 |
Why?
|
| Human Body | 1 | 2017 | 39 | 0.590 |
Why?
|
| Monokines | 3 | 2003 | 79 | 0.580 |
Why?
|
| Fatty Acids, Volatile | 3 | 2007 | 102 | 0.580 |
Why?
|
| Milk, Human | 7 | 2006 | 490 | 0.550 |
Why?
|
| Epithelium | 17 | 2007 | 1679 | 0.540 |
Why?
|
| Intestinal Diseases | 5 | 2005 | 530 | 0.490 |
Why?
|
| Hemoglobins | 2 | 2017 | 1532 | 0.460 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2009 | 134 | 0.460 |
Why?
|
| Gene Expression Regulation | 13 | 2007 | 12073 | 0.450 |
Why?
|
| Micronutrients | 3 | 2010 | 375 | 0.440 |
Why?
|
| Colitis, Ulcerative | 9 | 2021 | 1911 | 0.430 |
Why?
|
| Curcumin | 2 | 2010 | 96 | 0.410 |
Why?
|
| Caco-2 Cells | 11 | 2012 | 387 | 0.400 |
Why?
|
| Immunity, Mucosal | 5 | 2007 | 490 | 0.400 |
Why?
|
| HIV Enteropathy | 1 | 2010 | 6 | 0.380 |
Why?
|
| Gastrointestinal Tract | 3 | 2010 | 814 | 0.380 |
Why?
|
| Acetylation | 5 | 2009 | 1084 | 0.370 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2005 | 370 | 0.350 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 6 | 2003 | 216 | 0.330 |
Why?
|
| Stomach | 4 | 2013 | 697 | 0.330 |
Why?
|
| Enteral Nutrition | 3 | 2005 | 767 | 0.320 |
Why?
|
| Body Height | 3 | 2006 | 1578 | 0.320 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 1480 | 0.310 |
Why?
|
| Inulin | 1 | 2007 | 84 | 0.310 |
Why?
|
| Interleukin-1beta | 2 | 2012 | 972 | 0.310 |
Why?
|
| Toll-Like Receptors | 3 | 2006 | 593 | 0.310 |
Why?
|
| Lipopolysaccharides | 6 | 2011 | 2216 | 0.300 |
Why?
|
| Diet | 7 | 2007 | 7937 | 0.290 |
Why?
|
| Digestive System | 3 | 1997 | 253 | 0.290 |
Why?
|
| Nod Signaling Adaptor Proteins | 1 | 2006 | 2 | 0.290 |
Why?
|
| Androgens | 1 | 2014 | 1281 | 0.280 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2006 | 424 | 0.280 |
Why?
|
| Sp3 Transcription Factor | 1 | 2006 | 29 | 0.280 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 697 | 0.280 |
Why?
|
| beta-Thromboglobulin | 1 | 2006 | 24 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2015 | 4424 | 0.280 |
Why?
|
| Immune System | 3 | 2007 | 806 | 0.270 |
Why?
|
| Oligosaccharides | 1 | 2007 | 414 | 0.260 |
Why?
|
| Diarrhea | 5 | 2008 | 1348 | 0.260 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2014 | 1856 | 0.260 |
Why?
|
| Diarrhea, Infantile | 2 | 2018 | 109 | 0.260 |
Why?
|
| Gastrointestinal Agents | 2 | 2022 | 494 | 0.250 |
Why?
|
| Interleukin-10 | 2 | 2011 | 1200 | 0.250 |
Why?
|
| Colon | 5 | 2009 | 1772 | 0.250 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2006 | 708 | 0.250 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 4153 | 0.250 |
Why?
|
| Down-Regulation | 5 | 2012 | 3001 | 0.240 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 335 | 0.240 |
Why?
|
| Food, Formulated | 5 | 2004 | 109 | 0.230 |
Why?
|
| Intestinal Absorption | 7 | 1999 | 420 | 0.230 |
Why?
|
| Chemokines | 4 | 2002 | 970 | 0.230 |
Why?
|
| Matrix Metalloproteinases | 1 | 2006 | 391 | 0.230 |
Why?
|
| Pediatrics | 2 | 2017 | 3475 | 0.220 |
Why?
|
| Carrier Proteins | 4 | 2006 | 5023 | 0.220 |
Why?
|
| Receptors, Cell Surface | 2 | 2003 | 2865 | 0.220 |
Why?
|
| Feces | 4 | 2017 | 1401 | 0.220 |
Why?
|
| Ferritins | 2 | 2017 | 590 | 0.210 |
Why?
|
| RNA, Messenger | 13 | 2010 | 13035 | 0.210 |
Why?
|
| Interleukin-1 | 6 | 2003 | 1263 | 0.210 |
Why?
|
| Dextran Sulfate | 1 | 2003 | 236 | 0.210 |
Why?
|
| Inflammation | 8 | 2014 | 10637 | 0.200 |
Why?
|
| Signal Transduction | 12 | 2013 | 23404 | 0.200 |
Why?
|
| Iron | 4 | 2013 | 1774 | 0.190 |
Why?
|
| Child | 37 | 2022 | 77709 | 0.190 |
Why?
|
| Developed Countries | 1 | 2004 | 437 | 0.190 |
Why?
|
| Lactoferrin | 2 | 2006 | 97 | 0.190 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 1993 | 1475 | 0.180 |
Why?
|
| Epithelial Cells | 13 | 2018 | 3690 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2011 | 1790 | 0.180 |
Why?
|
| Colitis | 5 | 2011 | 1170 | 0.180 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1999 | 57 | 0.180 |
Why?
|
| Weaning | 2 | 2004 | 105 | 0.170 |
Why?
|
| Cell Division | 8 | 2004 | 4569 | 0.170 |
Why?
|
| Biological Therapy | 1 | 2020 | 138 | 0.170 |
Why?
|
| Humans | 104 | 2022 | 744366 | 0.170 |
Why?
|
| Dietary Supplements | 3 | 2011 | 3296 | 0.170 |
Why?
|
| Intestine, Large | 2 | 2011 | 71 | 0.170 |
Why?
|
| Interleukin-6 | 3 | 2005 | 3203 | 0.170 |
Why?
|
| Neutrophil Infiltration | 1 | 2001 | 391 | 0.170 |
Why?
|
| Transferrin | 2 | 2017 | 295 | 0.170 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2001 | 675 | 0.160 |
Why?
|
| Receptors, Growth Factor | 1 | 1999 | 334 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2013 | 4751 | 0.160 |
Why?
|
| Malabsorption Syndromes | 1 | 2018 | 135 | 0.160 |
Why?
|
| Cytokines | 6 | 2006 | 7323 | 0.150 |
Why?
|
| Animals | 36 | 2017 | 168768 | 0.150 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2017 | 88 | 0.150 |
Why?
|
| Epidermal Growth Factor | 2 | 1997 | 709 | 0.150 |
Why?
|
| Chemotactic Factors | 1 | 1997 | 199 | 0.150 |
Why?
|
| Chemokine CXCL2 | 3 | 2003 | 115 | 0.140 |
Why?
|
| Gastric Mucosa | 2 | 2013 | 599 | 0.140 |
Why?
|
| Genes, Regulator | 1 | 1997 | 378 | 0.140 |
Why?
|
| Helicobacter Infections | 2 | 2013 | 387 | 0.140 |
Why?
|
| Lactation | 1 | 1999 | 412 | 0.140 |
Why?
|
| Endothelial Growth Factors | 1 | 1999 | 694 | 0.140 |
Why?
|
| RNA | 2 | 2006 | 2749 | 0.140 |
Why?
|
| Antigens | 2 | 1993 | 1466 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 8 | 2004 | 6313 | 0.140 |
Why?
|
| Cell Differentiation | 11 | 2004 | 11486 | 0.140 |
Why?
|
| Mouth Diseases | 1 | 1998 | 241 | 0.140 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 426 | 0.140 |
Why?
|
| Lymphokines | 1 | 1999 | 949 | 0.140 |
Why?
|
| Infant, Newborn | 10 | 2017 | 25628 | 0.130 |
Why?
|
| Drug Monitoring | 1 | 2022 | 956 | 0.130 |
Why?
|
| Cell Polarity | 2 | 1998 | 645 | 0.130 |
Why?
|
| Zambia | 3 | 2010 | 261 | 0.130 |
Why?
|
| Peptides | 1 | 2007 | 4410 | 0.130 |
Why?
|
| Adolescent | 23 | 2020 | 85779 | 0.130 |
Why?
|
| Colectomy | 2 | 1999 | 680 | 0.130 |
Why?
|
| Nucleotides | 2 | 1996 | 464 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2013 | 565 | 0.120 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 379 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 3464 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2004 | 2926 | 0.120 |
Why?
|
| Chromosomes | 1 | 1997 | 596 | 0.120 |
Why?
|
| Antibodies | 4 | 2010 | 2460 | 0.120 |
Why?
|
| Cell Line | 11 | 2012 | 16000 | 0.120 |
Why?
|
| DNA | 3 | 2006 | 7294 | 0.120 |
Why?
|
| Azathioprine | 1 | 2015 | 354 | 0.120 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2005 | 329 | 0.120 |
Why?
|
| Enterocolitis | 2 | 1994 | 102 | 0.120 |
Why?
|
| Cholera Toxin | 1 | 1996 | 556 | 0.120 |
Why?
|
| Transcription Factors | 4 | 2010 | 12207 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 343 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2001 | 2617 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2007 | 5856 | 0.110 |
Why?
|
| Ileum | 2 | 1986 | 565 | 0.110 |
Why?
|
| Bone Diseases, Developmental | 1 | 2013 | 130 | 0.110 |
Why?
|
| Histones | 3 | 2000 | 2598 | 0.110 |
Why?
|
| NF-kappa B | 3 | 2007 | 2499 | 0.100 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1992 | 318 | 0.100 |
Why?
|
| Microvilli | 4 | 1996 | 241 | 0.100 |
Why?
|
| GTP-Binding Proteins | 1 | 1996 | 970 | 0.100 |
Why?
|
| Drosophila Proteins | 1 | 2001 | 1703 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2003 | 2962 | 0.100 |
Why?
|
| Developing Countries | 1 | 2004 | 2815 | 0.100 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1999 | 1660 | 0.100 |
Why?
|
| Abdominal Pain | 2 | 2013 | 1064 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2017 | 8300 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 1999 | 7721 | 0.100 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2010 | 9 | 0.100 |
Why?
|
| Permeability | 2 | 2010 | 738 | 0.100 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 1991 | 53 | 0.090 |
Why?
|
| Female | 38 | 2020 | 380193 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2012 | 222 | 0.090 |
Why?
|
| Barrett Esophagus | 2 | 2005 | 494 | 0.090 |
Why?
|
| Chemokines, CXC | 2 | 2003 | 422 | 0.090 |
Why?
|
| Lactobacillus | 1 | 2011 | 189 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3707 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2001 | 3771 | 0.090 |
Why?
|
| Nutritional Status | 3 | 2008 | 1609 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 4463 | 0.090 |
Why?
|
| Gene Expression | 5 | 2010 | 7798 | 0.090 |
Why?
|
| Child, Preschool | 9 | 2017 | 41005 | 0.090 |
Why?
|
| Male | 36 | 2020 | 350115 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 2 | 1996 | 1170 | 0.090 |
Why?
|
| Hypoaldosteronism | 1 | 1989 | 8 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2017 | 3914 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 264 | 0.090 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 4 | 3 | 2003 | 26 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2013 | 555 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 3 | 2003 | 76 | 0.080 |
Why?
|
| Biopsy | 6 | 2013 | 6755 | 0.080 |
Why?
|
| Cyclosporine | 1 | 1991 | 788 | 0.080 |
Why?
|
| Organ Culture Techniques | 3 | 2007 | 813 | 0.080 |
Why?
|
| Multivariate Analysis | 4 | 2012 | 12244 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 1996 | 1741 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2018 | 5451 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2012 | 721 | 0.080 |
Why?
|
| Infant | 11 | 2017 | 35134 | 0.080 |
Why?
|
| Butyric Acid | 2 | 1998 | 55 | 0.080 |
Why?
|
| Biological Transport, Active | 2 | 2006 | 349 | 0.080 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2010 | 362 | 0.080 |
Why?
|
| Mast Cells | 2 | 1986 | 1544 | 0.080 |
Why?
|
| Rhamnose | 1 | 1987 | 18 | 0.080 |
Why?
|
| Lactulose | 1 | 1987 | 33 | 0.080 |
Why?
|
| Purines | 1 | 2011 | 594 | 0.080 |
Why?
|
| Escherichia coli Vaccines | 1 | 2007 | 11 | 0.080 |
Why?
|
| Superantigens | 1 | 2007 | 129 | 0.080 |
Why?
|
| Malnutrition | 1 | 2014 | 625 | 0.080 |
Why?
|
| Tiopronin | 1 | 2007 | 3 | 0.080 |
Why?
|
| Helicobacter pylori | 2 | 2013 | 383 | 0.080 |
Why?
|
| Probiotics | 1 | 2011 | 351 | 0.080 |
Why?
|
| Lipopeptides | 1 | 2007 | 75 | 0.080 |
Why?
|
| Salivary Glands | 1 | 1989 | 229 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2009 | 8436 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2009 | 4162 | 0.070 |
Why?
|
| DNA-Binding Proteins | 3 | 2007 | 9647 | 0.070 |
Why?
|
| Spinal Cord Compression | 1 | 1989 | 235 | 0.070 |
Why?
|
| Spleen | 1 | 1993 | 2362 | 0.070 |
Why?
|
| I-kappa B Proteins | 1 | 2007 | 225 | 0.070 |
Why?
|
| Disaccharides | 1 | 1987 | 171 | 0.070 |
Why?
|
| Age Factors | 5 | 2017 | 18373 | 0.070 |
Why?
|
| Virus Physiological Phenomena | 1 | 2006 | 18 | 0.070 |
Why?
|
| Receptors, Chemokine | 2 | 2001 | 670 | 0.070 |
Why?
|
| Enteritis | 1 | 2007 | 165 | 0.070 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1989 | 281 | 0.070 |
Why?
|
| Transfection | 2 | 2007 | 5895 | 0.070 |
Why?
|
| Kinetics | 4 | 1999 | 6476 | 0.070 |
Why?
|
| Rats | 6 | 2011 | 24252 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2006 | 3749 | 0.070 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2006 | 21 | 0.070 |
Why?
|
| Cell Compartmentation | 1 | 2007 | 402 | 0.070 |
Why?
|
| Jejunal Diseases | 1 | 2006 | 50 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2011 | 1892 | 0.070 |
Why?
|
| Sucrase | 2 | 1996 | 54 | 0.070 |
Why?
|
| Enterotoxins | 1 | 2007 | 368 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 15520 | 0.070 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2005 | 68 | 0.070 |
Why?
|
| Gastroenteritis | 2 | 2007 | 245 | 0.070 |
Why?
|
| Genes, MHC Class II | 2 | 1999 | 457 | 0.070 |
Why?
|
| Colonic Neoplasms | 5 | 2000 | 2542 | 0.070 |
Why?
|
| Enzyme Activation | 2 | 2009 | 3702 | 0.070 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2006 | 121 | 0.070 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2000 | 341 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2556 | 0.070 |
Why?
|
| Dysentery, Amebic | 1 | 1984 | 7 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 147 | 0.060 |
Why?
|
| Gastrins | 1 | 2004 | 81 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 1677 | 0.060 |
Why?
|
| Keratins | 2 | 1996 | 515 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2006 | 5867 | 0.060 |
Why?
|
| Laminin | 2 | 1996 | 419 | 0.060 |
Why?
|
| Double-Blind Method | 3 | 2020 | 12025 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 1783 | 0.060 |
Why?
|
| Leukocytes | 2 | 2006 | 2045 | 0.060 |
Why?
|
| Duodenum | 2 | 2013 | 484 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 4 | 2007 | 6171 | 0.060 |
Why?
|
| Aldosterone | 1 | 1989 | 877 | 0.060 |
Why?
|
| Mice | 11 | 2017 | 81201 | 0.060 |
Why?
|
| Nucleosides | 2 | 1994 | 138 | 0.060 |
Why?
|
| Growth | 2 | 1999 | 376 | 0.060 |
Why?
|
| Herpes Simplex | 1 | 1987 | 470 | 0.060 |
Why?
|
| Interferon-gamma | 3 | 2001 | 3207 | 0.060 |
Why?
|
| Iodine Radioisotopes | 2 | 1999 | 1032 | 0.060 |
Why?
|
| Base Sequence | 3 | 2006 | 12797 | 0.060 |
Why?
|
| Apoptosis | 3 | 2013 | 9724 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2007 | 673 | 0.060 |
Why?
|
| Drug Combinations | 3 | 2003 | 1958 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 39052 | 0.060 |
Why?
|
| Adult | 15 | 2017 | 214052 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2005 | 1213 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 9735 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15535 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 1996 | 1581 | 0.050 |
Why?
|
| Chemotaxis | 1 | 2006 | 607 | 0.050 |
Why?
|
| Proteoglycans | 2 | 1996 | 837 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 1996 | 867 | 0.050 |
Why?
|
| Peroxidase | 2 | 2005 | 611 | 0.050 |
Why?
|
| Child Nutrition Disorders | 1 | 2004 | 149 | 0.050 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2004 | 303 | 0.050 |
Why?
|
| Urban Population | 1 | 2010 | 2022 | 0.050 |
Why?
|
| Age of Onset | 2 | 2006 | 3270 | 0.050 |
Why?
|
| Placebos | 2 | 2020 | 1676 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2010 | 10943 | 0.050 |
Why?
|
| Molecular Weight | 2 | 1995 | 2255 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2011 | 1580 | 0.050 |
Why?
|
| Gastroenterology | 2 | 2005 | 538 | 0.050 |
Why?
|
| Efferent Pathways | 1 | 2002 | 167 | 0.050 |
Why?
|
| Cycloleucine | 1 | 1980 | 9 | 0.050 |
Why?
|
| Wound Healing | 1 | 2012 | 2785 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2012 | 4222 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 3 | 2013 | 612 | 0.050 |
Why?
|
| Aminoisobutyric Acids | 1 | 1980 | 38 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 1989 | 1226 | 0.050 |
Why?
|
| Sexual Maturation | 1 | 2003 | 265 | 0.050 |
Why?
|
| Afferent Pathways | 1 | 2002 | 302 | 0.050 |
Why?
|
| Remission Induction | 2 | 2020 | 2385 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2012 | 4554 | 0.050 |
Why?
|
| Freeze Drying | 1 | 2020 | 98 | 0.050 |
Why?
|
| Respiratory Tract Infections | 1 | 2008 | 961 | 0.050 |
Why?
|
| Enterocytes | 2 | 2001 | 225 | 0.050 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2003 | 300 | 0.050 |
Why?
|
| Cryptosporidium parvum | 1 | 2001 | 43 | 0.050 |
Why?
|
| Medical Staff, Hospital | 1 | 2005 | 601 | 0.050 |
Why?
|
| DNA, Bacterial | 2 | 2020 | 1465 | 0.050 |
Why?
|
| Medication Adherence | 1 | 2012 | 2063 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 1 | 2010 | 1714 | 0.050 |
Why?
|
| Biological Transport | 3 | 1994 | 2120 | 0.050 |
Why?
|
| Cryptosporidiosis | 1 | 2001 | 60 | 0.050 |
Why?
|
| Dermatitis, Atopic | 1 | 1987 | 654 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2013 | 1683 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2004 | 593 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 1991 | 2134 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2004 | 1728 | 0.040 |
Why?
|
| Peristalsis | 1 | 1999 | 60 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2007 | 1453 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 2 | 1993 | 973 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1730 | 0.040 |
Why?
|
| Dialysis Solutions | 1 | 1999 | 38 | 0.040 |
Why?
|
| Celiac Disease | 1 | 2007 | 785 | 0.040 |
Why?
|
| Interleukins | 1 | 2003 | 791 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2004 | 754 | 0.040 |
Why?
|
| Adenocarcinoma | 6 | 2005 | 6364 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 1999 | 374 | 0.040 |
Why?
|
| Workload | 1 | 2005 | 849 | 0.040 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2001 | 354 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2022 | 53290 | 0.040 |
Why?
|
| Diet Therapy | 1 | 2000 | 154 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2006 | 5181 | 0.040 |
Why?
|
| Health Resources | 1 | 2005 | 911 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2007 | 1400 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 10183 | 0.040 |
Why?
|
| Hydroxamic Acids | 2 | 2000 | 494 | 0.040 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2018 | 200 | 0.040 |
Why?
|
| Neutrophil Activation | 1 | 1999 | 186 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 290 | 0.040 |
Why?
|
| Colonoscopy | 1 | 1986 | 1367 | 0.040 |
Why?
|
| Environment | 1 | 2004 | 1123 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1999 | 1157 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2018 | 209 | 0.040 |
Why?
|
| Digestive System Abnormalities | 1 | 1997 | 52 | 0.040 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1998 | 153 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 1985 | 1415 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1999 | 772 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2001 | 1101 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 2916 | 0.040 |
Why?
|
| Collagen | 2 | 1996 | 2688 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 954 | 0.040 |
Why?
|
| Culture Techniques | 1 | 1997 | 554 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 1999 | 619 | 0.040 |
Why?
|
| Serologic Tests | 1 | 1999 | 374 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 1999 | 405 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2013 | 758 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2005 | 1102 | 0.040 |
Why?
|
| Reference Values | 2 | 1999 | 4982 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 5 | 2013 | 21833 | 0.030 |
Why?
|
| Plastics | 1 | 1996 | 123 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 12802 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2012 | 2971 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 1999 | 664 | 0.030 |
Why?
|
| Aging | 2 | 2005 | 8664 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1996 | 321 | 0.030 |
Why?
|
| Adenosine Monophosphate | 2 | 1996 | 275 | 0.030 |
Why?
|
| Intestinal Neoplasms | 2 | 1995 | 319 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1996 | 357 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2001 | 1607 | 0.030 |
Why?
|
| Homeostasis | 1 | 2006 | 3339 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2005 | 1585 | 0.030 |
Why?
|
| Time Factors | 4 | 2007 | 40075 | 0.030 |
Why?
|
| Bacteria | 1 | 2005 | 2115 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2015 | 232 | 0.030 |
Why?
|
| Antineoplastic Agents | 3 | 2010 | 13693 | 0.030 |
Why?
|
| Headache | 1 | 1982 | 1226 | 0.030 |
Why?
|
| Amino Acids | 1 | 1980 | 1737 | 0.030 |
Why?
|
| Growth Substances | 2 | 1996 | 784 | 0.030 |
Why?
|
| Glycoside Hydrolases | 1 | 1994 | 133 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 11366 | 0.030 |
Why?
|
| Somatomedins | 1 | 1994 | 192 | 0.030 |
Why?
|
| Gestational Age | 3 | 2000 | 3493 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2010 | 2029 | 0.030 |
Why?
|
| Rectum | 1 | 1999 | 904 | 0.030 |
Why?
|
| Duodenoscopy | 1 | 2013 | 52 | 0.030 |
Why?
|
| Middle Aged | 10 | 2015 | 213390 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 1993 | 123 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1994 | 1572 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1996 | 1308 | 0.030 |
Why?
|
| London | 1 | 2013 | 233 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 1993 | 425 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 1999 | 12961 | 0.030 |
Why?
|
| Aprotinin | 1 | 1993 | 88 | 0.030 |
Why?
|
| Fetus | 2 | 2000 | 1880 | 0.030 |
Why?
|
| Neutrophils | 2 | 1999 | 3721 | 0.030 |
Why?
|
| Chile | 1 | 2013 | 237 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 4666 | 0.030 |
Why?
|
| Culture Media | 1 | 1995 | 909 | 0.030 |
Why?
|
| Child Development | 1 | 2004 | 2223 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1995 | 390 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1999 | 868 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 188 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1992 | 803 | 0.030 |
Why?
|
| Gastroscopy | 1 | 2013 | 207 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1995 | 694 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2012 | 135 | 0.030 |
Why?
|
| Cell Count | 2 | 1986 | 1856 | 0.020 |
Why?
|
| Portugal | 1 | 1991 | 87 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 1999 | 2076 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 9445 | 0.020 |
Why?
|
| Cell Survival | 2 | 2004 | 5882 | 0.020 |
Why?
|
| Biological Clocks | 1 | 1993 | 322 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 537 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2013 | 324 | 0.020 |
Why?
|
| Steroids | 2 | 1987 | 930 | 0.020 |
Why?
|
| Genotype | 1 | 2005 | 12952 | 0.020 |
Why?
|
| Stomatitis, Aphthous | 1 | 1991 | 53 | 0.020 |
Why?
|
| Interleukin-5 | 1 | 2011 | 273 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 18034 | 0.020 |
Why?
|
| Rectal Fistula | 1 | 1991 | 73 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2005 | 21748 | 0.020 |
Why?
|
| Hormones | 1 | 1994 | 889 | 0.020 |
Why?
|
| Aged | 7 | 2015 | 163288 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1998 | 3873 | 0.020 |
Why?
|
| Middle East | 1 | 1991 | 219 | 0.020 |
Why?
|
| Research Report | 1 | 2013 | 355 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 1454 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 1997 | 1613 | 0.020 |
Why?
|
| Behcet Syndrome | 1 | 1991 | 84 | 0.020 |
Why?
|
| Chronic Disease | 2 | 1999 | 9145 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1993 | 18111 | 0.020 |
Why?
|
| Pakistan | 1 | 1991 | 295 | 0.020 |
Why?
|
| Cell Line, Tumor | 4 | 2010 | 16690 | 0.020 |
Why?
|
| Ulcer | 1 | 1991 | 209 | 0.020 |
Why?
|
| Infant, Premature | 1 | 1999 | 2045 | 0.020 |
Why?
|
| Colorectal Neoplasms | 2 | 2013 | 6773 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 1865 | 0.020 |
Why?
|
| Comorbidity | 1 | 2004 | 10388 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2566 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2703 | 0.020 |
Why?
|
| Consanguinity | 1 | 1991 | 454 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2012 | 9849 | 0.020 |
Why?
|
| Brazil | 1 | 2013 | 1270 | 0.020 |
Why?
|
| Cattle | 1 | 1995 | 3922 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2013 | 19233 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 590 | 0.020 |
Why?
|
| Floxacillin | 1 | 2007 | 4 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1999 | 5974 | 0.020 |
Why?
|
| Drug Synergism | 2 | 2004 | 1794 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2010 | 253 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1999 | 3511 | 0.020 |
Why?
|
| Gastric Lavage | 1 | 2007 | 18 | 0.020 |
Why?
|
| Carcinoma | 1 | 1999 | 2375 | 0.020 |
Why?
|
| Erythema | 1 | 1989 | 257 | 0.020 |
Why?
|
| Radiography | 1 | 1999 | 7023 | 0.020 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2007 | 32 | 0.020 |
Why?
|
| Infant Nutrition Disorders | 1 | 2007 | 73 | 0.020 |
Why?
|
| beta Catenin | 1 | 2012 | 1059 | 0.020 |
Why?
|
| Ileitis | 1 | 1987 | 44 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 1993 | 1284 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2007 | 370 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 1915 | 0.020 |
Why?
|
| Organoids | 1 | 2013 | 701 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1989 | 1681 | 0.020 |
Why?
|
| Logistic Models | 2 | 2012 | 13409 | 0.020 |
Why?
|
| Gerbillinae | 1 | 2006 | 89 | 0.020 |
Why?
|
| Acyclovir | 1 | 1987 | 272 | 0.020 |
Why?
|
| Histamine Release | 1 | 1986 | 142 | 0.020 |
Why?
|
| Hyponatremia | 1 | 1989 | 298 | 0.020 |
Why?
|
| Sulfasalazine | 1 | 1986 | 79 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 712 | 0.020 |
Why?
|
| Retroviridae Infections | 1 | 1986 | 151 | 0.020 |
Why?
|
| Enema | 1 | 1986 | 141 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 2005 | 219 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2011 | 77460 | 0.020 |
Why?
|
| Consultants | 1 | 2005 | 53 | 0.020 |
Why?
|
| Insulin | 1 | 2000 | 6582 | 0.020 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 2004 | 7 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 1986 | 588 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 365 | 0.020 |
Why?
|
| Dyspepsia | 1 | 2006 | 116 | 0.020 |
Why?
|
| Prednisolone | 1 | 1986 | 334 | 0.020 |
Why?
|
| Nitrobenzenes | 1 | 2004 | 65 | 0.020 |
Why?
|
| Joint Diseases | 1 | 1989 | 479 | 0.020 |
Why?
|
| Caspase 10 | 1 | 2004 | 4 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2011 | 775 | 0.020 |
Why?
|
| Potassium | 1 | 1989 | 1336 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2004 | 104 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 1988 | 532 | 0.010 |
Why?
|
| Hygiene | 1 | 2004 | 97 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1993 | 6621 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2004 | 195 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 2004 | 231 | 0.010 |
Why?
|
| Sodium | 1 | 1989 | 1622 | 0.010 |
Why?
|
| Obesity | 1 | 2005 | 12746 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 2007 | 650 | 0.010 |
Why?
|
| Prognosis | 2 | 1999 | 29060 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2020 | 63107 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2943 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 644 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 1997 | 14561 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 7914 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 371 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 2560 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2004 | 320 | 0.010 |
Why?
|
| Random Allocation | 1 | 1987 | 2428 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 6386 | 0.010 |
Why?
|
| HIV Infections | 1 | 2008 | 16715 | 0.010 |
Why?
|
| Antioxidants | 1 | 2010 | 1659 | 0.010 |
Why?
|
| Rana ridibunda | 1 | 1980 | 2 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2008 | 2715 | 0.010 |
Why?
|
| Nitroarginine | 1 | 2001 | 66 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1980 | 65 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 2001 | 111 | 0.010 |
Why?
|
| Young Adult | 3 | 2012 | 56429 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1989 | 1810 | 0.010 |
Why?
|
| HT29 Cells | 1 | 2001 | 200 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 2001 | 115 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 20952 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 928 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2000 | 149 | 0.010 |
Why?
|
| Cell Movement | 1 | 2012 | 5218 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1986 | 1463 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 1115 | 0.010 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 3799 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 2007 | 7182 | 0.010 |
Why?
|
| Glucose | 1 | 1991 | 4398 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 4561 | 0.010 |
Why?
|
| Anthropometry | 1 | 2004 | 1350 | 0.010 |
Why?
|
| Tryptophan | 1 | 2001 | 478 | 0.010 |
Why?
|
| Phenotype | 1 | 1996 | 16367 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2000 | 271 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2000 | 472 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2004 | 1101 | 0.010 |
Why?
|
| Portal Vein | 1 | 1980 | 437 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2005 | 975 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2887 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 57776 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 915 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6539 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 2005 | 7882 | 0.010 |
Why?
|
| Mesoderm | 1 | 2000 | 686 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2000 | 638 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 1984 | 622 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1980 | 1525 | 0.010 |
Why?
|
| Mortality | 1 | 2008 | 2864 | 0.010 |
Why?
|
| Body Weight | 1 | 2007 | 4671 | 0.010 |
Why?
|
| Cytidine Monophosphate | 1 | 1996 | 19 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15221 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 2418 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 2126 | 0.010 |
Why?
|
| Peyer's Patches | 1 | 1996 | 121 | 0.010 |
Why?
|
| Leptin | 1 | 2004 | 1600 | 0.010 |
Why?
|
| Liver | 1 | 2011 | 7475 | 0.010 |
Why?
|
| Research | 1 | 2004 | 1999 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1996 | 295 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2004 | 1940 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2969 | 0.010 |
Why?
|
| Guanosine | 1 | 1994 | 61 | 0.010 |
Why?
|
| Thymidine | 1 | 1994 | 310 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 1996 | 316 | 0.010 |
Why?
|
| Cytidine | 1 | 1994 | 68 | 0.010 |
Why?
|
| Inosine | 1 | 1994 | 133 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1994 | 411 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1993 | 149 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 9955 | 0.010 |
Why?
|
| Hospitalization | 1 | 2012 | 10259 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1993 | 919 | 0.010 |
Why?
|
| Trypsin | 1 | 1993 | 511 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2004 | 3778 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2004 | 3743 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1993 | 642 | 0.010 |
Why?
|
| Vaccination | 1 | 2004 | 3279 | 0.010 |
Why?
|
| Health Promotion | 1 | 2004 | 2205 | 0.010 |
Why?
|
| Risk Factors | 1 | 1999 | 72296 | 0.010 |
Why?
|
| Pregnancy | 1 | 1993 | 29144 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1993 | 719 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1993 | 590 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 1993 | 233 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1989 | 9240 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14723 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 25039 | 0.010 |
Why?
|
| Adenosine | 1 | 1994 | 825 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 4034 | 0.010 |
Why?
|
| Exercise | 1 | 2005 | 5615 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1996 | 1434 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2004 | 10483 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 13991 | 0.000 |
Why?
|
| Neoplasms | 2 | 2010 | 21696 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1993 | 1182 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7282 | 0.000 |
Why?
|
| Deltaretrovirus | 1 | 1986 | 170 | 0.000 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1996 | 2949 | 0.000 |
Why?
|
| Syndrome | 1 | 1989 | 3252 | 0.000 |
Why?
|
| Hypertension | 1 | 1982 | 8479 | 0.000 |
Why?
|